Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Geographic Atrophy (GA)”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Testing effectiveness (Phase 2)Ended earlyNCT05019521
What this trial is testing

Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Alexion Pharmaceuticals, Inc. 365
Not applicableStudy completedNCT07424235
What this trial is testing

Evaluating the Relationship Between Function and Structure in ARCHER II-like Population Using Data From a Natural History Cohort

Who this might be right for
Age Related Macular Degeneration (AMD)Age Related Macular DegenerationAMD+3 more
IRCCS Ospedale San Raffaele 60
Testing effectiveness (Phase 2)Looking for participantsNCT06659445
What this trial is testing

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

Who this might be right for
Geographic Atrophy (GA)Age - Related Macular Degeneration (AMD)
ONL Therapeutics 324
Large-scale testing (Phase 3)Looking for participantsNCT06541704
What this trial is testing

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Who this might be right for
Age-related Macular Degeneration (AMD)Geographic Atrophy (GA)
Regeneron Pharmaceuticals 975
Testing effectiveness (Phase 2)Study completedNCT01632527
What this trial is testing

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular DegenerationMacular DegenerationAMD
StemCells, Inc. 15
Early research (Phase 1)Study completedNCT03295877
What this trial is testing

Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic Atrophy
Genentech, Inc. 28
Testing effectiveness (Phase 2)Ended earlyNCT02467634
What this trial is testing

Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD

Who this might be right for
Age-Related Macular Degeneration
StemCells, Inc. 3
Testing effectiveness (Phase 2)Ended earlyNCT00695318
What this trial is testing

Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy

Who this might be right for
Age-Related Macular Degeneration
Alimera Sciences 17
Large-scale testing (Phase 3)Study completedNCT04435366
What this trial is testing

Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

Who this might be right for
Geographic AtrophyMacular Degeneration
IVERIC bio, Inc. 448
Testing effectiveness (Phase 2)Ended earlyNCT05893537
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Who this might be right for
Age-Related Macular Degeneration
Cognition Therapeutics 100
Large-scale testing (Phase 3)Study completedNCT01802866
What this trial is testing

Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride

Who this might be right for
Geographic Atrophy
Kubota Vision Inc. 508
Large-scale testing (Phase 3)Study completedNCT03525600
What this trial is testing

Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Apellis Pharmaceuticals, Inc. 621
Testing effectiveness (Phase 2)WithdrawnNCT02895815
What this trial is testing

Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)

Who this might be right for
Visual AcuityGeographic AtrophyMacular Degeneration
Janssen Pharmaceutical K.K.
Not applicableUnknownNCT03688243
What this trial is testing

Non Exudative AMD Imaged With SS-OCT

Who this might be right for
Dry Macular Degeneration
Boston Image Reading Center 225
Not applicableStudy completedNCT02051998
What this trial is testing

Directional Spread in Geographic Atrophy

Who this might be right for
Nonexudative Age-related Macular Degeneration
University Hospital, Bonn 130
Early research (Phase 1)Study completedNCT04246866
What this trial is testing

First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyMacular Degeneration+2 more
Gemini Therapeutics, Inc. 12
Testing effectiveness (Phase 2)WithdrawnNCT04358471
What this trial is testing

Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyGene Therapy+1 more
Hemera Biosciences
Testing effectiveness (Phase 2)Study completedNCT00766649
What this trial is testing

Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMD

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 11
Early research (Phase 1)Study completedNCT03777332
What this trial is testing

Study to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic Atrophy

Who this might be right for
Geographic Atrophy
Apellis Pharmaceuticals, Inc. 19
Large-scale testing (Phase 3)Active Not RecruitingNCT06510816
What this trial is testing

A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy
Annexon, Inc. 659
Load More Results